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Articles

Use of quantitative molecular diagnostic methods to
investigate the effect of enteropathogen infections on linear
growth in children in low-resource settings: longitudinal
analysis of results from the MAL-ED cohort study
Elizabeth T Rogawski*, Jie Liu*, James A Platts-Mills, Furqan Kabir, Paphavee Lertsethtakarn, Mery Siguas, Shaila S Khan, Ira Praharaj,
Arinao Murei, Rosemary Nshama, Buliga Mujaga, Alexandre Havt, Irene A Maciel, Darwin J Operario, Mami Taniuchi, Jean Gratz,
Suzanne E Stroup, James H Roberts, Adil Kalam, Fatima Aziz, Shahida Qureshi, M Ohedul Islam, Pimmada Sakpaisal, Sasikorn Silapong,
Pablo P Yori, Revathi Rajendiran, Blossom Benny, Monica McGrath, Jessica C Seidman, Dennis Lang, Michael Gottlieb, Richard L Guerrant,
Aldo A M Lima, Jose Paulo Leite, Amidou Samie, Pascal O Bessong, Nicola Page, Ladaporn Bodhidatta, Carl Mason, Sanjaya Shrestha, Ireen Kiwelu,
Estomih R Mduma, Najeeha T Iqbal, Zulfiqar A Bhutta, Tahmeed Ahmed, Rashidul Haque, Gagandeep Kang, Margaret N Kosek, Eric R Houpt,
and The MAL-ED Network Investigators†

Summary

Background Enteropathogen infections in early childhood not only cause diarrhoea but contribute to poor growth. We
used molecular diagnostics to assess whether particular enteropathogens were associated with linear growth across
seven low-resource settings.
Methods We used quantitative PCR to detect 29 enteropathogens in diarrhoeal and non-diarrhoeal stools collected
from children in the first 2 years of life obtained during the Etiology, Risk Factors, and Interactions of Enteric
Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED) multisite cohort
study. Length was measured monthly. We estimated associations between aetiology-specific diarrhoea and subclinical
enteropathogen infection and quantity and attained length in 3 month intervals, at age 2 and 5 years, and used a
longitudinal model to account for temporality and time-dependent confounding.
Findings Among 1469 children who completed 2 year follow-up, 35 622 stool samples were tested and yielded valid
results. Diarrhoeal episodes attributed to bacteria and parasites, but not viruses, were associated with small decreases in
length after 3 months and at age 2 years. Substantial decrements in length at 2 years were associated with subclinical,
non-diarrhoeal, infection with Shigella (length-for-age Z score [LAZ] reduction –0·14, 95% CI –0·27 to –0·01),
enteroaggregative Escherichia coli (–0·21, –0·37 to –0·05), Campylobacter (–0·17, –0·32 to –0·01), and Giardia (–0·17,
–0·30 to –0·05). Norovirus, Cryptosporidium, typical enteropathogenic E coli, and Enterocytozoon bieneusi were also
associated with small decrements in LAZ. Shigella and E bieneusi were associated with the largest decreases in LAZ
per log increase in quantity per g of stool (–0·13 LAZ, 95% CI –0·22 to –0·03 for Shigella; –0·14, –0·26 to –0·02 for
E bieneusi). Based on these models, interventions that successfully decrease exposure to Shigella, enteroaggregative E coli,
Campylobacter, and Giardia could increase mean length of children by 0·12–0·37 LAZ (0·4–1·2 cm) at the MAL-ED sites.
Interpretation Subclinical infection and quantity of pathogens, particularly Shigella, enteroaggregative E coli,
Campylobacter, and Giardia, had a substantial negative association with linear growth, which was sustained during
the first 2 years of life, and in some cases, to 5 years. Successfully reducing exposure to certain pathogens might
reduce global stunting.
Funding Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Introduction
Poor linear growth is an intractable public health issue.
Stunting, which is defined as more than two standard
deviations below the WHO height-for-age standard,1
affects more than 30% of children in low-resource
settings.2 Impaired linear growth is a cumulative marker
of chronic undernutrition that is associated with high
mortality,3 chronic disease, poor school performance,
and low adult economic productivity.4,5

Stunting occurs in the context of poverty and results
from the interaction of multiple inter-related factors in the
prenatal and postnatal environments. Childhood diarrhoea
has been recognised as an important determinant of
linear growth for decades.6–8 Diarrhoea due to particular
pathogens, such as Shigella and enterotoxigenic Escherichia
coli, has been associated with poor height attainment and
poor weight gain, respectively, whereas rotavirus has been
shown to have little effect on ponderal or linear growth.6,9
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Research in context
Evidence before this study
We searched PubMed for articles published in any language
since Jan 1, 1990, using the search terms “(enteric infection) OR
enteropathogen OR diarrhea OR diarrhoea)” AND “(pediatric
OR paediatric OR infant* OR children)” AND “(grow* OR linear
OR height OR length OR stunting OR stunted)” AND “cohort”.
With the exception of the Etiology, Risk Factors, and
Interactions of Enteric Infections and Malnutrition and the
Consequences for Child Health and Development study
reported here, we identified 759 publications, of which
20 investigated the association between enteropathogens and
child growth. All studies were done at a single site: six focused
on aetiology-specific diarrhoea without assessment of
subclinical infection and 18 assessed only one pathogen.
Only one study used quantitative molecular diagnostic
methods to detect enteropathogens.

Implications of all the available evidence
Our results showed that subclinical infection and quantity of
Shigella, enteroaggregative Escherichia coli, Campylobacter,
and Giardia were negatively associated with linear growth, and
had larger effect on linear growth than diarrhoeal episodes.
Successfully reducing exposure to these pathogens might
reduce global stunting.

The Etiology, Risk Factors, and Interactions of Enteric
Infections and Malnutrition and the Consequences
for Child Health and Development (MAL-ED) study10
was a multisite longitudinal birth cohort that assessed
the effect of enteric infections and other risk factors
on linear growth. In contrast to earlier studies,6–8
diarrhoea did not have a consistently significant effect on
height attainment.11,12 Potential reasons included
declining diarrhoeal incidence, mild diarrhoeal episodes
captured by active surveillance, and high rates of healthcare referral. Specific diarrhoeal aetiologies might have
had an effect; however, this has not yet been investigated
because assigning the aetiology of diarrhoea to specific
pathogens is most accurate with the use of quantitative
molecular diagnostic testing.13
Conversely, subclinical infection with enteropathogens,
independent of diarrhoea, was strongly associated with
poor height attainment in the MAL-ED study.11,12 High
prevalence of Campylobacter and enteroaggregative E coli,
the two most prevalent enteropathogens among children
in the MAL-ED study, were each associated with
approximately 0·8 cm shorter length at 2 years compared
with a low prevalence of these pathogens. However, these
findings were derived from a subset of stool specimens
tested with culture and immunoassay diagnostics, which
have lower sensitivity than PCR,13 thus pathogen
prevalence was underestimated.
We used quantitative molecular diagnostics to assess
the association between 29 pathogens and linear growth
using stool specimens from the MAL-ED study.

February, 2012. Linear anthro
pometric measurements
were available from seven locations: Dhaka, Bangladesh;
Vellore, India; Bhaktapur, Nepal; Fortaleza, Brazil;
Loreto, Peru; Venda, South Africa; and Haydom,
Tanzania. Children were included if their mother was
aged 16 years or older, their family intended to remain in
the study area for at least 6 months from enrolment, they
were from a singleton pregnancy, they had no other
siblings enrolled in the study, and had a birthweight or
enrolment weight of more than 1500 g. Children
diagnosed with congenital disease or severe neonatal
disease were excluded. All sites received ethical approval
from their respective governmental, local institutional,
and collaborating institutional ethics review boards.
Written informed consent was obtained from the parent
or guardian of every child.

Methods

Stool testing

The MAL-ED study design has been described
previously.10 Children were enrolled within 17 days of
birth at eight locations between November, 2009, and

We tested all stool specimens using custom-designed
TaqMan Array Cards (ThermoFisher, Carlsbad, CA,
USA) that compartmentalised probe-based quantitative
PCR assays for 29 enteropathogens (appendix). Assay

Study design and participants

2

Added value of this study
This study provides a comprehensive, multisite assessment of
the effect of enteropathogen infections on linear growth
during the first 2 years of life using quantitative PCR for a broad
range of enteropathogens in the context of home-based
surveillance. These high-resolution data allowed for a rigorous
longitudinal analysis that accounted for temporality, lag
periods for pathogen effects, and potential confounding by
infections with other pathogens.

Samples
Fieldworkers visited children twice weekly until age
2 years for active surveillance of child illnesses, antibiotic
use, breastfeeding, and food intake. Sociodemographic
information was collected every 6 months. Linear
anthropometric measurements were obtained by field
workers monthly to age 2 years (length) and once at age
5 years (±6 months; height).11 Diarrhoeal stools were
defined by maternal report of three or more loose stools
in 24 h or one stool with visible blood. Non-diarrhoeal
stool samples were collected monthly (at least 3 days
before or after a diarrhoea episode) from birth to age
2 years.
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vali
dation, nucleic acid extraction, quantitative PCR
con
ditions, and quality control have been previously
described.13,14 Both Shigella and enteroinvasive E coli are
detected using the ipaH target; however, on the basis of
previous findings that Shigella flexneri and Shigella
sonnei account for the majority of ipaH detections,13 and
Shigella positive stool cultures are metagenomically
similar to ipaH positive stools,15 for simplicity the
presence of ipaH was considered diagnostic of Shigella.

Procedures
Pathogen-specific aetiology of diarrhoea was determined
using attributable fractions (AFe) to adjust for subclinical
pathogen infections, as previously described.13,16,17 We
defined pathogen-attributable episodes when the pathogen
quantity-derived AFe was 0·5 or higher (ie, majority
attribution). Episodes with a sum of all pathogen-specific
AFes of less than 0·5 (ie, the majority of the episode was
not attributed to pathogens) were considered nonattributable. We assessed the associations between
diarrhoeal aetiologies and growth for diarrhoea episodes
attributable to any infection, and to viral, parasitic, and
bacterial pathogen groups (appendix). We also assessed
individual pathogens, specifically the ten enteropathogens
with the highest attributable diarrhoeal incidence in the
MAL-ED study (identified in the companion Article16):
Shigella, typical enteropatho
genic E coli, Campylobacter
Dhaka,
Bangladesh
(n=210)
Diarrhoeal stools with valid
results, n
Median per child (IQR)
Non-diarrhoeal stools with valid
results, n
Median per child (IQR)

1390
6 (4–9)
4342
21 (19–22)

Vellore,
India
(n=227)
666
2 (1–4)
4881
22 (21–23)

jejuni or Campylobacter coli, enterotoxigenic E coli,
Cryptosporidium, astrovirus, sapovirus, norovirus,
rotavirus, and adenovirus 40/41. For the subclinical
infection and growth analysis, we assessed all 29 pathogens
(appendix) and included the 13 most prevalent pathogens
as covariates in the models (including all pathogens with
significant associations with growth in the height attain
ment model): enteroaggregative E coli, enterotoxigenic
E coli, Giardia, Campylobacter, atypical enteropathogenic
E coli, adenovirus 40/41, sapovirus, typical enteropathogenic
E coli, norovirus, Shigella, astrovirus, Enterocytozoon
bieneusi and Cryptosporidium. Length measurements were
converted into length-for-age Z scores (LAZ) using 2006
WHO child growth standards.18 Socioeconomic status was
summarised using a construct of water, assets, maternal
education, and income11,15 and was averaged over four
biannual surveys. Exclusive breastfeeding was defined as
the proportion of days in a specified time period in which
children were breastfed and received no liquids or solids.
Potential confounders were included on the basis of
previous associations with enteropathogen exposure19–21
and linear growth.11

Statistical analysis
To estimate the associations between aetiology-specific
diarrhoea and linear growth after 3 months, we used
repeated measures linear regression with general

Bhaktapur,
Nepal
(n=227)
911
3 (2–6)
5061
23 (22–23)

Venda,
South Africa
(n=237)
132

Haydom,
Tanzania
(n=209)
164

0 (0–1)
4877
21 (19–22)

0 (0–1)
4331
21 (20–22)

Fortaleza,
Brazil
(n=165)
97
0 (0–1)
2926
18 (15–20)

Loreto,
Peru
(n=194)
1615
7 (4–11)
4229
22 (21–23)

Total
(n=1469)
4975
2 (0–5)
30 647
21 (20–23)

Sex
Female, n (%)

102 (49%)

122 (54%)

105 (46%)

117 (49%)

104 (50%)

76 (46%)

89 (46%)

715 (49%)

Male, n (%)

108 (51%)

105 (46%)

122 (54%)

120 (51%)

105 (50%)

89 (54%)

105 (54%)

754 (51%)

Improved sanitation, n (%)*

210 (100%)

132 (58%)

227 (100%)

232 (98%)

19 (9%)

165 (100%)

100 (52%)

1084 (74%)

Improved drinking water, n (%)*

210 (100%)

227 (100%)

227 (100%)

216 (91%)

128 (61%)

165 (100%)

192 (99%)

1365 (93%)

Mean maternal height, cm (SD)

145 (5·0)

151 (5·2)

149 (5·2)

158 (6·5)

156 (5·8)

155 (6·7)

150 (5·6)

153 (6·7)

Mean maternal age, years (SD)
Mean monthly income <150 US$
(IQR)

25·0 (5·0)

23·9 (4·2)

26·6 (3·7)

27·0 (7·2)

29·1 (6·5)

25·4 (5·6)

132 (62·9)

209 (92·1)

111 (48·9)

44 (18·6)

206 (98·6)

3 (1·8)

24·8 (6·3)
138 (71·3)

26·0 (5·8)
843 (57·4)

Median months of exclusive
breastfeeding (IQR)

5·1 (3·8–5·8)

3·5 (2·4–4·6)

3·0 (1·4–4·4)

1·0 (0·6–1·7)

1·9 (1·2–2·7)

2·6 (1·6–4·4)

2·9 (1·1–4·8)

2·6 (1·3–4·4)

Median number of diarrhoea
episodes (IQR)

7 (4–9)

4 (2–6)

4 (2–7)

1 (0–2)

2 (1–4)

1 (0–2)

7·5 (5–12)

3 (1–6)

Mean enrolment WAZ†

–1·26 (0·94)

–1·30 (1·04)

–0·92 (0·97)

–0·38 (0·95)

–0·13 (0·94)

–0·16 (1·05)

–0·62 (0·91)

–0·70 (1·07)

Mean enrolment LAZ†

–0·97 (1·01)

–1·02 (1·05)

–0·72 (1·03)

–0·71 (1·00)

–1·03 (1·14)

–0·80 (1·13)

–0·95 (0·96)

–0·88 (1·05)

Mean WAZ at 2 years

–1·61 (0·99)

–1·65 (0·94)

–0·93 (0·90)

–0·51 (0·98)

–1·33 (1·01)

0·39 (1·21)

–0·79 (0·90)

–0·96 (1·17)

Mean LAZ at 2 years

–2·03 (0·94)

–1·92 (0·97)

–1·35 (0·92)

–1·70 (1·06)

–2·67 (1·02)

–0·04 (1·08)

–1·88 (0·87)

–1·70 (1·20)

MAL-ED=The Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development study. WAZ=weight-for-age Z score. LAZ=length-for-age
Z scores. *Individuals with access to improved sanitation and drinking water as defined by WHO guidelines.24 †Measured within 17 days of birth.

Table: Baseline characteristics, pathogen prevalence, and linear growth outcomes among 1469 children in the MAL-ED cohort with molecular testing of stool samples
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0·4
0·3

Difference in LAZ after 3 months per episode
Difference in LAZ at 2 years between high and low
diarrhoea burden

0·2

Difference in LAZ (95% CI)

0·1
0
–0·1
–0·2
–0·3
–0·4
–0·5
–0·6
–0·7

Any cause Any infectious
aetiology

Bacterial

Viral

Parasitic

Figure 1: Associations between diarrhoea and LAZ
Analysis includes 37 951 observed child-months among 1469 children in the
Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition
and the Consequences for Child Health and Development cohort study who had
molecular testing of stool samples. Per-episode estimates were adjusted for age,
site, sex, socioeconomic status , maternal height, LAZ at the beginning of the
interval, exclusive breastfeeding, and non-attributable diarrhoea episodes in the
same period. 2 year estimates were adjusted for site, sex, socioeconomic status,
maternal height, enrolment LAZ, exclusive breastfeeding in the first 6 months,
number of antibiotic courses, and number of non-attributable diarrhoea
episodes. LAZ=length-for-age Z scores.

estimating equations to account for correlation between
children’s outcomes over time. Models were adjusted for
age, site, sex, socioeconomic status, maternal height,
LAZ at the beginning of the interval, exclusive
breastfeeding, and number of non-attributable diarrhoea
episodes in the same period. We also estimated the
associations of diarrhoea with fever, dehydration,
vomiting, blood, prolonged duration (diarrhoea for 7 days
or longer), and high severity (modified Vesikari score >6)22
with LAZ after 3 months. We used linear regression to
estimate associations between aetiology-specific diarr
hoea episodes and LAZ measured at 2 years (acceptable
window for measurement was age 731 days ±15 days) in a
height attainment model. Models were adjusted for
enrolment LAZ, sex, socioeconomic status, exclusive
breastfeeding in the first 6 months, maternal height,
number of non-attributable diarrhoea episodes, and
number of episodes treated with any antibiotics. Effects
were estimated for the difference in LAZ at 2 years and
scaled to compare a high burden of attributable diarrhoea
episodes with a low burden (ie, the difference between
the 90th and 10th percentile).
We used linear regression to estimate associations
between subclinical enteropathogen infections and LAZ
measured at 2 years in a height attainment model,
adjusting for site, enrolment LAZ, sex, socioeconomic
status, exclusive breastfeeding in the first 6 months, and
maternal height. Exposure to each enteropathogen was
summarised as the proportion of non-diarrhoeal stools
4

obtained between age 1 and 24 months that were positive
for that enteropathogen. The summative effect of
pathogen groups was assessed by calculating the mean
number of detections between age 1 and 24 months. The
difference in LAZ at 2 years associated with each pathogen
was scaled to compare the 90th percentile with the
10th percentile for stool positivity (appendix). In a second
analysis, we specified pathogen quantity in non-diarrhoeal
stools as the exposure, defined by mean log-copy number
per g of stool (appendix) and scaled effects per one log
increase in pathogen quantity. In a sensitivity analysis, we
specified enteropathogen exposure as the proportion of
all positive stools (non-diarrhoeal and diarrhoeal)
obtained between age 1 and 24 months. We also estimated
the associations of enteropathogen exposures with
weight-for-age and weight-for-length Z scores in models
with the same structure, additionally adjusting for
enrolment weight-for-age Z scores. We estimated the
associations with height-for-age Z score at 5 years of age
(±6 months) in a model with the same structure.
To ensure temporality and include potential lag periods
between exposures and growth, we investigated entero
pathogens in longitudinal models. We defined exposures
in 6 month intervals from birth to 2 years and used the
parametric g-formula23 to model interim effects on LAZ
at the end of the intervals and overall effect on LAZ at
2 years. The parametric g-formula was fitted for each
pathogen individually, specified first as the proportion of
positive non-diarrhoeal stools and second as the mean
quantity in non-diarrhoeal stools during the 6 month
interval. Pathogen exposures were assessed with a
flexible lag structure including the exposure in the current
and previous intervals (appendix). All models were
adjusted for the five pathogens with the strongest
associations with LAZ at 2 years. We first used the observed
data to estimate β-coefficients in longitudinal repeated
measures models for each time-dependent covariate in
the 6 month intervals (appendix). We used Monte Carlo
simulations with the estimated coefficients to predict the
time-dependent covariates, pathogen exposures, and
LAZ outcomes for each interval to age 2 years in a
random sample of 50 000 replicates from the study
population at baseline. Simulations were run for high
(90th percentile in each interval) and low (10th percentile
in each interval) pathogen exposure conditions and the
difference due to a one log increase in pathogen quantity.
We estimated the cumulative effect of pathogens on LAZ
by calculating the difference of the mean predicted
outcomes at 2 years between the high and low exposure
conditions (population-standardised LAZ difference).
strapping at the
95% CIs were constructed by boot
individual level to account for correlation between
observations over time with 1000 replicates.

Role of the funding source
The funder of the study had no role in study design, data
collection, data analysis, data interpretation, or writing of
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the report. The corresponding author had full access to
all data in the study and had final responsibility for the
decision to submit for publication.

Results
Among 1868 children enrolled at seven sites, 1469 (79%)
were followed up with anthropometry until age 2 years,
of whom 1202 had available anthropometry data
at age 5 years (±6 months). Mean LAZ within 17 days of
birth was slightly less than one standard deviation below
the WHO standard, and by age 2 years was almost
two standard deviations below the WHO standard
(table). We obtained 37 433 stool specimens, of which
35 622 (95%; 30 647 non-diarrhoeal stools and
4975 diarrhoeal stools collected from 94% of diarrhoeal
episodes) yielded valid quantitative PCR results for at
least one enteropathogen and were included in the
analysis.
Detection by quantitative PCR

Proportion of
positive stools (%)

100

Diarrhoea of any cause occurred in 6296 child-months
(mean 4·3 episodes per child between 0 and 2 years),
diarrhoea due to any infectious aetiology in
3018 child-months (any quantitative aetiologic pathogen
detection; mean 2·1 episodes per child between age 0 and
2 years), bacterial diarrhoea (attributable to enter-
oaggregative Escherichia coli, atypical enteropathogenic
E coli, typical enteropathogenic E coli, enterotoxigenic
E coli, Shiga toxin-producing E coli, Aeromonas, C jejuni or
C coli, Helicobacter pylori, Plesiomonas shigelloides,
Salmonella, Shigella, or Vibrio cholera) in 1245 child-months
(mean 0·9 episodes per child between age 0 and 2 years),
viral diarrhoea (attributable to adenovirus 40/41,
astrovirus, norovirus GI or GII, rotavirus, or sapovirus) in
1962 child-months (mean 1·4 episodes per child between
age 0 and 2 years), and parasitic diarrhoea (attributable to
E bieneusi, Encephalitozoon intestinalis, Cryptosporidium,
Cyclospora, Isospora, Entamoeba histolytica, Giardia,

Detection by previous conventional diagnostic methods

Detection using both methods

EAEC

Giardia

Campylobacter

aEPEC

LT-ETEC

ST-ETEC

Adenovirus
40/41

Sapovirus

tEPEC

Norovirus GII

Shigella

Astrovirus

Cryptosporidium

Enterocytozoon
bieneusi
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Figure 2: Enteropathogen prevalence in non-diarrhoeal stools obtained from 1469 children in the MAL-ED cohort with molecular testing of stool samples
MAL-ED=Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development. EAEC=enteroaggregative Escherichia coli. aEPEC=atypical
enteropathogenic E coli. LT-ETEC=heat-labile enterotoxigenic E coli. ST-ETEC=heat-stable enterotoxigenic E coli. tEPEC=typical enteropathogenic E coli. STEC=Shiga toxin-producing E coli.
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Figure 3: Site-specific effects of enteropathogen infections on height at age 2 years
Difference in LAZ at age 2 years between site-specific high and low combined pathogen prevalence in
non-diarrhoeal stools among 1469 children in the Etiology, Risk Factors, and Interactions of Enteric Infections and
Malnutrition and the Consequences for Child Health and Development cohort. Bacteria include Campylobacter,
Shigella, enteroaggregative Escherichia coli, typical enteropathogenic E coli, atypical enteropathogenic E coli, and
enterotoxigenic E coli; viruses include norovirus, adenovirus 40/41, astrovirus, and sapovirus; and protozoa include
Giardia, Cryptosporidium, and Enterocytozoon bieneusi (the latter is an intracellular parasitic fungus). Estimates were
adjusted for site, enrolment LAZ, sex, socioeconomic status, exclusive breastfeeding in the first 6 months, and
maternal height. LAZ=length-for-age Z scores.

Ancylostoma, Strongyloides, or Trichuris) in 149 childmonths (mean 0·1 episodes per child between age 0 and
2 years). Diarrhoea of any cause and infectious diarrhoea
episodes were associated with small reductions in
LAZ after 3 months (figure 1). The difference in
LAZ score varied on the basis of site (appendix) and
diarrhoeal aetiology (pheterogeneity<0·001). Associations
between aetiology-specific diarrhoea and LAZ after
3 months were stronger for bacterial and parasitic
diarrhoea than viral diarrhoea. Aetiology-specific episodes
attributable to Shigella (LAZ difference –0·03, 95% CI
–0·05 to –0·00), enterotoxigenic E coli (–0·04, –0·07 to
–0·01), Cryptosporidium (–0·06,–0·13 to 0·00), norovirus
(–0·04,–0·08 to 0·00), and adenovirus 40/41 (–0·05,
–0·08 to –0·02) were negatively associated with LAZ after
3 months. No short-term associations were identified
between LAZ and other specific pathogens (appendix).
Diarrhoea episodes with blood (LAZ difference –0·06,
95% CI –0·10 to –0·01), prolonged duration (–0·04, –0·07
to –0·01), and high severity (–0·04, –0·08 to –0·01) were
independently associated with reductions in short-term
linear growth regardless of aetiology. The cumulative
effect of infectious diarrhoea episodes on LAZ at age
2 years was less precise, but showed that a high burden of
diarrhoea due to any aetiology was associated with a
decrease of –0·16 in LAZ (95% CI –0·37 to 0·06) at age
2 years. Similar to the short-term models, the associations
with LAZ varied according to diarrhoeal aetiology
(figure 1).
The prevalence of enteropathogen infections detected
by quantitative PCR in all non-diarrhoeal stools was
6

higher than that reported pre
viously using previous
conventional diagnostic methods, which were mainly
culture and immunoassay17 (figure 2): of the nondiarrhoeal stools with valid quantitative PCR results,
enteroaggregative E coli was most prevalent at all sites
(15 314 [51%] of 30 034 stools), followed by enterotoxigenic
E coli (9056 [30%] of 30 172 stools), Giardia (8898 [30%]
of 30 006 stools) and Campylobacter (8398 [28%] of
30 030 stools; appendix). The prevalence of helminths
was low (843 [2·8%] of 29 971 stools). Subclinical entero
pathogen infections had stronger negative and more
significant associations with LAZ at age 2 years than did
infectious diarrhoea. A high burden of subclinical
infections (90th percentile of detection prevalence) was
associated with a LAZ difference of –0·41 (95% CI
–0·61 to –0·21) compared with a low burden of
subclinical infections (10th percentile; figure 3).
Similarly, infections with bacteria and protozoa at the
90th percentile of detection prevalence (combining all
sites) were associated with a difference in LAZ of –0·25
(95% CI –0·45 to –0·05) and –0·22 (95% CI
–0·36 to –0·08) at 2 years, respectively, compared with
detection of these pathogens at the 10th percentile
(figure 3). Infections with viruses had no overall effect.
High prevalence of enteroaggregative E coli
(LAZ reduction –0·21, 95% CI –0·37 to –0·05), Giardia
(–0·17, –0·30 to –0·05), Campylobacter (–0·17, –0·32 to
–0·01), Shigella (–0·14, –0·27 to –0·01), and E bieneusi
(–0·14, –0·27 to –0·01) in non-diarrhoeal stools were
associated with decrements in LAZ at age 2 years
(figure 4A). Detection of typical enteropathogenic E coli
was associated with a small decrement in LAZ, whereas
all other pathogens were not associated with LAZ in the
height attainment model. The association between
enterotoxigenic E coli and LAZ did not differ according
to the toxins identified, and the association between
enteroaggregative E coli and LAZ did not change if the
detection of the aggR gene was used to define
enteroaggregative E coli instead of aaiC or aatA genes
(data not shown).
Shigella and E bieneusi were associated with the largest
decreases in LAZ (–0·13 LAZ, 95% CI –0·22 to –0·03
for Shigella; –0·14,–0·26 to –0·02 for E bieneusi) per
log increase in quantity per g of stool (figure 4B).
Enteroaggregative E coli, Giardia, and Campylobacter were
associated with smaller decrements in LAZ using this
exposure specification (ie, quantity rather than prevalence).
In the subset of 1202 children with height measurements
at age 5 years, most associations between pathogen
burden in the first 2 years of life and height-for-age
Z scores at 5 years were slightly smaller than those at
2 years (figure 4), with the exception of Shigella and
norovirus, for which the associations were sustained or
increased. The inclusion of diarrhoeal stools in the
measure of pathogen exposure did not increase the effects
on LAZ observed for non-diarrhoeal stools alone
(appendix). Associations between pathogens and
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Discussion
The incorporation of sensitive and quantitative molecular
diagnostics to identify both symptomatic and subclinical
enteric infections across seven diverse sites allowed a
high-resolution examination of the effects of these
pathogens on childhood growth. Although diarrhoea
episodes, including pathogen-attributable episodes, had
small short-term associations with length, their
associations with length were smaller at 2 years and were
less than half the magnitude of those for subclinical
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weight-for-age and weight-for-length Z scores were similar
(appendix). When comparing the findings derived from
the quanti
tative PCR detection methods versus the
conventional diagnostics of culture and immunoassay, the
most notable difference was for Shigella, which was not
associated with LAZ using the conventional diagnostics
because of the relative insensitivity of culture (appendix).
In the logitudinal model, mean LAZ at each interval for
the high and low pathogen exposure conditions showed
that the largest differences in length associated with
pathogen exposure accrued in the second year of life were
coincident with increases in pathogen prevalence
(figure 5). These models generally supported the results
from the height attainment model. For example, the
population-standardised LAZ difference at age 2 years
between the high and low enteroaggregative E coli exposure
conditions was –0·23 (95% CI –0·46 to 0·00), similar to
the estimate from the height attainment model. The
negative differences in LAZ observed at age 2 years were
smaller and 95% CIs were wide for Shigella, Giardia,
Campylobacter, and typical enteropathogenic E coli. High
prevalence of Cryptosporidium, norovirus, and astrovirus,
which were not associated with LAZ in the height
attainment model, were associated with small decrements
in LAZ by age 2 years in the longitudinal model. Although
E bieneusi had a significant association in the height
attainment model (LAZ difference –0·14, 95% CI
–0·27 to –0·01), no association was identified in the
longitudinal model (LAZ difference at 2 years 0·03,
95% CI –0·17 to –0·23). The longitudinal models showed
little or no effect attributable to adenovirus 40/41, sapovirus,
atypical enteropathogenic E coli, or enterotoxigenic E coli.
The effects of pathogen quantities on LAZ was similar to
that of pathogen prevalence; the per log quantity-based
effect was slightly larger for Shigella and astrovirus, and
smaller for Campylobacter, enteroaggregative E coli, and
Giardia (appendix).
An intervention that could prevent all exposure to
the four pathogens most consistently associated with
poor linear growth (Shigella, enteroaggregative E coli,
Campylobacter, and Giardia), would be expected to
increase mean LAZ at 2 years by 0·24 (95% CI
0·08 to 0·41; 0·75 cm). The effect would be expected to
range from 0·12–0·37 LAZ (0·4–1·2 cm) across sites,
with the largest effect at sites with a high burden of
enteropathogens and stunting.

Bacteria

Viruses

Protozoa

Figure 4: Effect of specific enteropathogen infections on height attainment at age 2 and 5 years
Difference in LAZ according to high and low pathogen prevalence (A) and per one log increase in the mean
quantity of pathogen per g of stool (B) in non-diarrhoeal stools. Data were available for 1469 children at 2 years
and 1202 children at 5 years in the Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition
and the Consequences for Child Health and Development cohort. Estimates were adjusted for site, enrolment LAZ,
sex, SES, exclusive breastfeeding in the first 6 months, and maternal height. LAZ=length-for-age Z scores.
EAEC=enteroaggregative Escherichia coli. tEPEC= typical enteropathogenic E coli. ETEC=enterotoxigenic E coli.
aEPEC=atypical enteropathogenic E coli. *Enterocytozoon bieneusi is an intracellular parasitic fungus.

infections. Conversely, subclinical infections of certain
enteropathogens were associated with substantial and
sustained linear growth deficits.
Subclinical infections with bacteria had larger and more
consistent associations with larger decrements in LAZ
than those of viruses or protozoa. Not all bacteria had the
same effect: enteroaggregative E coli, Campylobacter, and
Shigella infection resulted in the largest population-level
differences in LAZ. The associations between decrements
in LAZ and enteroaggregative E coli21 and Campylobacter19
have been described previously using previous diagnostic
testing methods and were confirmed in this study. By
contrast, the association between Shigella prevalence and
decrement in LAZ score was an important finding that
has not been identified previously using cell culture,11
which might be due to the relative insensitivity of Shigella
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Figure 5: Mean LAZ from birth to age 2 years in the high and low enteropathogen infection burden
parametric g-formula conditions
The LAZ difference and 95% CI comparing the two conditions at 2 years is overlaid on each graph, for the 13 most
prevalent enteropathogens in non-diarrhoeal stools. LAZ=length-for-age Z scores. EAEC=enteroaggregative Escherichia
coli. tEPEC=typical enteropathogenic E coli. ETEC=enterotoxigenic E coli. aEPEC=atypical enteropathogenic E coli.

culture. Similarly, we were able to detect E bieneusi in
this analysis because of the broad PCR-based approach.
These findings reflect a combined metric determined
by both the pathogen’s prevelance at the populationlevel, regardless of quantity, and its association with
poor growth. When pathogen quantity was examined
8

independently of prevalence, Shigella had the largest
association with decrements in LAZ, suggesting it is the
most potently deleterious pathogen for growth. Shigella
infections in the first 2 years of life also had a sustained
effect on height at age 5 years. Our analysis also identified
an association between Giardia and poor linear growth
not apparent previously,20 which is likely to be a result
of monthly sampling in the second year of life, which
was more frequent than in previous analyses.20 Helminths
have traditionally been associated with malnutrition,25
but prevalence was low (2·8%) in this age group, resulting
in null and imprecise associations. A previous study26
reported that Cryptosporidium is associated with poor
growth, consistent with our results in the longitudinal
model.
Although the mechanisms by which subclinical
infections lead to impaired growth are not fully defined,
the pathway is thought to involve environmental enteric
dysfunction and inflammation.5,27 Shigella has long been
associated with inflammatory diarrhoea. Campylobacter19
and enteroaggregative E coli21 were also associated
with intestinal inflammation in the MAL-ED study,
and Giardia was associated with intestinal permeability
and malabsorption.20 E bieneusi has been associated
with intestinal malabsorption in patients with HIV.28
The association between norovirus infection and
short height at 5 years, and low weight-for-age Z score
and weight-for-height Z score at 2 years, differs from the
other viruses and merits further investigation.
Based on these observational data, a public health
intervention that could prevent infections with Shigella,
enteroaggregative E coli, Campylobacter, and Giardia at
the MAL-ED sites would be expected to increase mean
length of children at 2 years by 0·75 cm, with a larger
effect (1·2 cm) observed at sites with high pathogen
burden and stunting. The magnitude of this difference is
similar to or exceeds that of nutritional supplementation
trials (observed increase in LAZ of approximately
0·25),29–31 and this estimate requires experimental
investigation. Water, sanitation, and hygiene inter
ventions seem promising, but large trials29,30 have shown
little effect on linear growth. It would be useful to
assess how well these interventions reduce subclinical
enteropathogen infections. Vaccines are not available for
any of these four pathogens; however, Shigella32 and
C jejuni or C coli33 vaccines are in early phase development
to prevent diarrhoea. How effectively these vaccines will
reduce subclinical infection is unclear. Timing could be
important, since the longitudinal model suggests that
the growth impact of Shigella and Giardia occurs mostly
in the second year of life, whereas Campylobacter and
enteroaggregative E coli have an effect at an earlier age.
Antimicrobial strategies could be tested, since evidence34,35
indicates that antibiotics can improve child weight and
linear growth, with careful consideration of antimicrobial
resistance. Considering Shigella’s consistent, potent, and
sustained associations with low LAZ, we speculate that
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improved diagnosis and treatment of Shigella diarrhoea
could be particularly useful to target Shigella infection
and transmission.16
Strengths of this study include the equitable
quantitative PCR approach for all 29 enteropathogens,
which enabled us to compare and control for other
pathogens. The use of multiple statistical models allowed
us to assess the consistency of findings. We believe the
longitudinal model is the least biased because it reduces
the potential for reverse causality (ie, that undernutrition
increases risk of infections) by ensuring the directionality
from pathogen exposure to growth in 6 month periods.
For example, the association of E bieneusi in the height
attainment but not longitudinal models suggests that
rather than the pathogen causing poor linear growth,
undernourished children are infected with E bieneusi.
Consistency between the longitudinal and height attain
ment models for most other pathogens suggests reverse
causality does not explain these associations. The
longitudinal model also allows visualisation of catch-up
growth, highlighted by adenovirus 40/41. Additionally,
the incorporation of multiple time periods for the same
child with and without diarrhoea limits confounding by
fixed child-specific factors such as socioeconomic status.
A limitation of the longitudinal model is that estimates
were less precise than those from the height attainment
model, driven by the relatively small number of children
sampled at each site. Another limitation of this study is
that rare but severe infections, and infections in the first
year of life when enteropathogens were less prevalent,
would be expected to have little effect at the population
level, but could still have substantial effects at the individual
level. Additionally, most diarrhoeal episodes captured in
this community-based observational cohort were mild;
therefore, we might be underestimating the growth impact
of diarrhoea in populations with more severe disease.
A previous study36 has shown that the morbidity burden
of childhood diarrhoea increases substantially when
secondary effects on malnutrition are included in
estimates. Our results indicate that even these diarrhoea
morbidity estimates are substan
tially underestimating
the full impact of enteropathogens by not considering
subclinical infections. Moreover, specific enteropathogens
have varying effects. Some enteropathogens are asso
ciated primarily with poor growth attainment
(eg, enteroaggregative E coli and Giardia), some are
associated with both diarrhoea and poor growth
(eg, Shigella, Campylobacter, and norovirus), and some
are associated primarily with diarrhoea (eg, rotavirus,
sapovirus, adenovirus, and enterotoxigenic E coli).
In summary, focused strategies to prevent or reduce
subclinical infection duration or quantity of a small
number of select enteropathogens might contribute to
reductions in stunting globally. Reducing the full burden
of enteropathogens will require novel interventions that
can tackle not only diarrhoea but also subclinical
infections.
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